All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

34

Reset

34 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • EloralintideLY3841136Phase 313 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • NNC0487-0111Phase 312 trials

    Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • Novo Nordisk · Obesity, Overweight, Obstructive Sleep Apnoea

  • EcnoglutideXW003, VRB-101Phase 38 trials

    Hangzhou Sciwind Biosciences Co., Ltd. · Obesity, Weight Management, OSA - Obstructive Sleep Apnea

  • hUC-MSCsmesenchymal stem cells, MSCPhase 38 trials

    Shenzhen Wingor Biotechnology Co., Ltd. · Knee Osteoarthritis, Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)

  • RibupatideKAI-9531Phase 35 trials

    Kailera · Obesity, Overweight, Obesity With Diabetes

  • EtoricoxibPhase 34 trials

    Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain

  • JOINTSTEMPhase 32 trials

    R-Bio · Knee Osteoarthritis, Osteoarthritis, Knee

  • Reference DrugNSAIDsPhase 32 trials

    SANGMYUNG innovation · Retinal Vein Occlusion With Macular Edema, Knee Osteoarthritis

  • RTX-GRT7039Phase 32 trials

    Grünenthal GmbH · Osteoarthritis

  • TG-CTissueGene-CPhase 32 trials

    Kolon TissueGene, Inc. · Degenerative Osteoarthritis

  • CLS2901Chuman [allogeneic] chondrocyte sheetsPhase 31 trial

    CellSeed Inc. · Osteoarthritis of the Knee

  • PTP-01MOTYS, allogeneic human placental tissue particulatePhase 31 trial

    Doron Therapeutics Inc. · Knee Osteoarthritis

  • SL1002Phase 31 trial

    Saol Therapeutics Inc · Osteoarthritis Knee Pain

  • [StroMedPhase 23 trials

    VivaTech International, Inc. · Osteoarthritis

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • mesenchymal stem cellumbilical cord derived MSCsPhase 23 trials

    Cell Energy Life Sciences Group Co. LTD · AIDS, Ischemic Heart Disease, Osteoarthritis

  • AllocetraPhase 22 trials

    Enlivex Therapeutics Ltd. · Primary Knee Osteoarthritis, Osteoarthritis, Knee

  • DFV890Phase 22 trials

    Novartis · Coronary Heart Disease, Symptomatic Knee Osteoarthritis

  • Medipost Co Ltd. · Knee Osteoarthritis, Bronchopulmonary Dysplasia, BPD

  • TTAX03Phase 22 trials

    BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis

  • VutiglabridinHSG4112Phase 22 trials

    Glaceum · Knee Osteoarthritis (Knee OA), Parkinson Disease

  • AD-211-HPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-211-LPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-211-MPhase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • AD-2113Phase 21 trial

    Addpharma Inc. · Osteoarthritis of the Knees

  • CX-011Phase 21 trial

    CarthroniX, Inc. · Osteoarthritis of the Knees

  • KBP-336Phase 21 trial

    KeyBioscience AG · Osteoarthritis in the Knee, Obesity

  • NCR100Phase 21 trial

    Nuwacell Biotechnologies Co., Ltd. · Knee Osteoarthritis

  • PPV-06Phase 21 trial

    Peptinov SAS · Osteoarthritis, Knee

  • PTP-001Phase 21 trial

    Bioventus LLC · Osteoarthritis, Knee

  • RHH646Phase 21 trial

    Novartis · Osteoarthritis, Knee

  • SYN321Phase 21 trial

    Synartro AB · Osteoarthritis of Knee

  • TPX-100Phase 21 trial

    OrthoTrophix, Inc · Osteoarthritis (OA) of the Knee

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.